We are live on ! Find out more
MD icon

Pediatrix Medical

229 hedge funds and large institutions have $1.08B invested in Pediatrix Medical in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 80 increasing their positions, 74 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,161% more call options, than puts

Call options by funds: $701K | Put options by funds: $31K

59% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 22

8% more capital invested

Capital invested by funds: $995M → $1.08B (+$84.6M)

5% more funds holding

Funds holding: 218229 (+11)

8% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 74

4.29% less ownership

Funds ownership: 100.11%95.82% (-4.3%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
229
Holders Change
+11
Holders Change %
+5.05%
% of All Funds
3.02%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
35
Increased
80
Reduced
74
Closed
22
Calls
$701K
Puts
$31K
Net Calls
+$670K
Net Calls Change
+$328K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$186M +$4.78M +346,306 +3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$142M +$1.57M +113,976 +1%
AllianceBernstein
3
AllianceBernstein
Tennessee
$96.4M -$10.5M -759,605 -9%
State Street
4
State Street
Massachusetts
$47M +$600K +43,440 +1%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$42.8M -$213K -15,422 -0.5%
RCMNY
6
Rubric Capital Management (New York)
New York
$41.3M -$70.8M -5,126,560 -62%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$38.1M +$40M +2,896,518 +29,433%
Pacer Advisors
8
Pacer Advisors
Pennsylvania
$35.5M +$37.3M +2,705,151 New
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$28.1M -$2.51M -182,007 -8%
Boston Partners
10
Boston Partners
Massachusetts
$25.9M +$5.43M +393,600 +25%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$25.6M +$152K +11,045 +0.6%
American Century Companies
12
American Century Companies
Missouri
$22.8M +$20.7M +1,500,485 +628%
Morgan Stanley
13
Morgan Stanley
New York
$17.2M -$29.8M -2,159,435 -62%
Charles Schwab
14
Charles Schwab
California
$15.2M -$2.89M -209,105 -15%
Northern Trust
15
Northern Trust
Illinois
$12.7M +$2.04M +147,522 +18%
JP Morgan Chase
16
JP Morgan Chase
New York
$12.2M -$148K -10,712 -1%
Renaissance Technologies
17
Renaissance Technologies
New York
$11M +$6.25M +453,000 +117%
DIA
18
Dana Investment Advisors
Wisconsin
$10.8M -$1.22M -88,725 -10%
Prudential Financial
19
Prudential Financial
New Jersey
$10.6M +$644K +46,635 +6%
ACH
20
ArrowMark Colorado Holdings
Colorado
$10.5M +$211K +15,249 +2%
Invesco
21
Invesco
Georgia
$10.4M -$3.59M -259,880 -25%
BIP
22
Brandes Investment Partners
California
$10.3M -$399K -28,890 -4%
SBH
23
Segall Bryant & Hamill
Illinois
$10.3M -$6.39M -463,071 -37%
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$9.99M +$7M +507,120 +200%
Goldman Sachs
25
Goldman Sachs
New York
$8.76M -$2.54M -183,679 -22%

MD Hedge Fund Activity: Q4 2024 in Review

229 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2024, worth a combined $1.08B — up 8.5% from $995M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new MD positions and 22 closed out — a net gain of 13 holders — while 80 added to existing stakes and 74 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $40M. The largest seller was Rubric Capital Management (New York), cutting an estimated $70.8M.

  • 229 institutional investors held Pediatrix Medical (MD) as of Q4 2024, up from 218 in Q3 2024.
  • Funds reported $1.08B of Pediatrix Medical stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 35 funds opened new Pediatrix Medical positions in Q4 2024 and 22 closed out, a net change of +13 holders.
  • The largest Pediatrix Medical buyer in Q4 2024 was Fidelity Investments, an estimated $40M added.
  • The largest Pediatrix Medical seller in Q4 2024 was Rubric Capital Management (New York), an estimated $70.8M sold.

Based on aggregated 13F filings for Q4 2024.